Diagnostic Ability of Methods Depicting Distress of Tumor-Bearing Mice.
3Rs
animal model
animal welfare
in vivo
xenograft models
Journal
Animals : an open access journal from MDPI
ISSN: 2076-2615
Titre abrégé: Animals (Basel)
Pays: Switzerland
ID NLM: 101635614
Informations de publication
Date de publication:
21 Jul 2021
21 Jul 2021
Historique:
received:
11
06
2021
revised:
15
07
2021
accepted:
17
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Subcutaneous tumor models in mice are the most commonly used experimental animal models in cancer research. To improve animal welfare and the quality of scientific studies, the distress of experimental animals needs to be minimized. For this purpose, one must assess the diagnostic ability of readout parameters to evaluate distress. In this study, we evaluated different noninvasive readout parameters such as body weight change, adjusted body weight change, faecal corticosterone metabolites concentration, burrowing activity and a distress score by utilising receiver operating characteristic curves. Eighteen immunocompromised NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice were used for this study; half were subcutaneously injected with A-375 cells (human malignant melanoma cells) that resulted in large tumors. The remaining mice were inoculated with SCL-2 cells (cutaneous squamous cell carcinoma cells), which resulted in small tumors. The adjusted body weight and faecal corticosterone metabolites concentration had a high diagnostic ability in distinguishing between mice before cancer cell injection and mice bearing large tumors. All other readout parameters had a low diagnostic ability. These results suggest that adjusted body weight and faecal corticosterone metabolites are useful to depict the distress of mice bearing large subcutaneous tumors.
Identifiants
pubmed: 34438613
pii: ani11082155
doi: 10.3390/ani11082155
pmc: PMC8388504
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : ZE 712/1-1, ZE 712/1-2, VO 450/15-1 and VO 450/15-2
Organisme : European Social Fund
ID : ESF/14-BM-A55-0003/18
Références
Physiol Behav. 2019 Feb 1;199:229-243
pubmed: 30468744
BMC Med Imaging. 2008 Oct 16;8:16
pubmed: 18925932
Sci Rep. 2019 Oct 23;9(1):15211
pubmed: 31645617
Br J Cancer. 1998;77(1):1-10
pubmed: 9459138
Animals (Basel). 2019 Nov 21;9(12):
pubmed: 31766349
Ann N Y Acad Sci. 2020 Aug;1473(1):20-34
pubmed: 32207155
Am J Bioeth. 2009 Dec;9(12):55-9
pubmed: 20013503
Adv Healthc Mater. 2020 Jun;9(12):e2000110
pubmed: 32367687
Animals (Basel). 2019 Apr 03;9(4):
pubmed: 30987232
Horm Behav. 2004 Jan;45(1):10-22
pubmed: 14733887
Nutrients. 2020 Oct 19;12(10):
pubmed: 33086629
In Vivo. 2013 Mar-Apr;27(2):189-96
pubmed: 23422477
Lab Anim. 2020 Feb;54(1):99-110
pubmed: 31665969
Nat Rev Clin Oncol. 2016 Apr;13(4):209-27
pubmed: 26718105
ALTEX. 2019 Dec 09;37(2):197-207
pubmed: 31825086
Lab Anim. 2015 Oct;49(4):284-93
pubmed: 25650386
Lab Anim. 2018 Aug;52(4):351-364
pubmed: 29207902
Front Behav Neurosci. 2010 Oct 12;4:165
pubmed: 21031028
Br J Anaesth. 1998 Aug;81(2):216-23
pubmed: 9813526
Dig Dis Sci. 2018 Jan;63(1):135-145
pubmed: 29214422
PLoS One. 2016 Jul 27;11(7):e0158390
pubmed: 27463392
PLoS One. 2020 Jan 27;15(1):e0228413
pubmed: 31986185
Lab Anim (NY). 2013 Mar;42(3):92-8
pubmed: 23423298
BMJ. 2017 Jan 25;356:j108
pubmed: 28122812
Comp Med. 2019 Dec 1;69(6):501-509
pubmed: 31315692
J Adv Res. 2019 Sep 14;21:35-47
pubmed: 31641536
In Vivo. 2019 Jul-Aug;33(4):1125-1132
pubmed: 31280201
ILAR J. 2000;41(2):87-93
pubmed: 11417496
Animals (Basel). 2020 Dec 05;10(12):
pubmed: 33291366
Invest Radiol. 2020 Aug;55(8):507-514
pubmed: 32224718
Gen Comp Endocrinol. 2003 Feb 15;130(3):267-78
pubmed: 12606269
Br J Cancer. 2010 May 25;102(11):1555-77
pubmed: 20502460
Toxicol Res. 2014 Mar;30(1):1-5
pubmed: 24795792
Domest Anim Endocrinol. 2002 Jul;23(1-2):67-74
pubmed: 12142227
Comp Med. 2009 Jun;59(3):234-41
pubmed: 19619413
Cancer Res. 1998 Jul 1;58(13):2825-31
pubmed: 9661897
Stress. 2013 Sep;16(5):571-80
pubmed: 23688070
Br J Pharmacol. 2012 Jul;166(5):1600-2
pubmed: 22364106
N Engl J Med. 2005 Oct 20;353(16):1659-72
pubmed: 16236737